<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2025.14941</article-id>
<article-id pub-id-type="publisher-id">OL-29-4-14941</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] MicroRNA‑592 targets IGF‑1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wenyao</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hongfei</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Tang</surname><given-names>Mao</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Longlong</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Zhengfang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Shaojun</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lichao</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>04</month>
<year>2025</year></pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>02</month>
<year>2025</year></pub-date>
<volume>29</volume>
<issue>4</issue>
<elocation-id>195</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2025 Wang et al.</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 13: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="13" page="3522" id="RA1" xlink:href="10.3892/ol.2017.5902" ext-link-type="doi">3522&#x2013;3528</related-article>, 2017; DOI: 10.3892/ol.2017.5902</p>
<p>Following the publication of this article, a concerned reader drew to the attention of the Editorial Office that the data panels for the Transwell cell invasion and migration assay data shown in Fig. 4A and B on p. 3526 contained a number of overlapping sections, such that these data apparently originated from the same original sources where the results from differently performed experiments were intended to have been portrayed. Moreover, certain of these data had already been submitted for publication in the following paper, written by different authors at different research institutes [Ni J, Yang Y, Liu D, Sun H, Jin S and Li J: MicroRNA-429 inhibits gastric cancer migration and invasion through the downregulation of specificity protein 1. Oncol Lett 13: 3845-3849, 2017].</p>
<p>Owing to the large number of overlapping data panels identified in Fig. 4A and B, and the fact that these data had already been submitted for publication in a different article to <italic>Oncology Letters</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
